Bruker Corp. Aktie
32,48 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 1,24 % | 5,66 % | -23,67 % | -35,53 % | -20,37 % | - | - |
| Healthequity Inc. | 0,76 % | 7,26 % | -6,99 % | -36,67 % | -14,74 % | 8,13 % | 3,91 % |
| Omnicell Inc. | 0,00 % | 6,54 % | -22,01 % | -13,30 % | -15,98 % | -34,80 % | -68,95 % |
| Myriad Genetics | -0,54 % | -1,60 % | -23,97 % | -74,08 % | -30,57 % | -79,63 % | -85,14 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




